Company intelligence / Profile preview

Saiiv Monitoring Solutions

Sydney, New South Wales, Australiasaiiv.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Saiiv's AI-powered wearable devices use proprietary Morphic Sensors to provide continuous, non-invasive monitoring of vital signs. Clinical trials are ongoing to validate their effectiveness in early detection and management of multimorbidities such as heart failure. The technology aims to improve patient outcomes by enabling earlier intervention and more personalized care plans.

Therapeutic areas: OtherCardiovascular
Modalities: DeviceWearable deviceTheir technology is not a drug or biologic, but rather a non-invasive monitoring device and digital health platform.
Industry: Physiological Monitoring

Partnerships

Western Sydney UniversityUniversity of SydneyNSW Smart Sensing Network’s Grand Challenges Fund

Beyond the preview

Go deeper on Saiiv Monitoring Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saiiv Monitoring Solutions.

Explore the full profile